JP Patent

JP6770946B2 — ２−フルオロ−ｎ−メチル−４−［７−（キノリン−６−イルメチル）イミダゾ［１，２−ｂ］［１，２，４］トリアジン−２−イル］ベンズアミドの錠剤

Assigned to ノバルティスアーゲー · Expires 2020-10-21 · 6y expired

What this patent protects

Patent listed against capmatinib-hydrochloride.

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: JP6770946B2
Jurisdiction: JP
Classification: —
Expires: 2020-10-21
Drug substance claim: No
Drug product claim: No
Assignee: ノバルティスアーゲー
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.